Neupro Side Effects in Detail. Generic Name: rotigotine. Note: This page contains side effects data for the generic drug rotigotine. It is possible that some of the dosage forms included below may not apply to the brand name Neupro. In Summary. Common side effects of Neupro include: insomnia, nausea, vomiting, and application site reaction. Other side effects include: dizziness, dyspepsia, increased blood pressure, orthostatic hypotension, increased heart rate, and orthostatic dizziness. Neupro Patch official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Medscape - Alzheimer disease and restless legs dosing for Neupro (rotigotine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information. Learn about drug side effects and interactions for the drug Neupro (Rotigotine Transdermal System). Major Side Effects. If any of the following side effects occur while taking rotigotine, check with your doctor immediately: More common: Burning, itching, redness, skin rash, swelling, or soreness at the application siteswelling of the hands, ankles, feet, or lower legs. Neupro Transdermal patch - 24 Hour drug summary. Find medication information including related drug classes, side effects, patient statistics and answers to frequently asked questions. Visit cvs.com for more details. Less common: Bladder painbloody or cloudy urineblurred vision or other changes in visiondifficult, burning, or painful urinationdizzinessfrequent urge to urinateheadachelower back or side painnervousnesspounding in the earsseeing, hearing, or feeling things that are not thereslow or fast heartbeat. If any of the following symptoms of overdose occur while taking rotigotine, get emergency help immediately: Symptoms of overdose: Confusionconvulsionsdizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting positionnauseasweatingunusual tiredness or weaknessvomiting. Minor Side Effects. Some rotigotine side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them: More common: Sleepiness or unusual drowsiness. Less common: Acid or sour stomachbelchingdifficulty having a bowel movement (stool)difficulty with movingdreaming abnormaldry mouthfeeling of constant movement of self or surroundingsheartburnindigestionloss of appetitemuscle pain or stiffnesspain in the jointssensation of spinningsleeplessnessstomach discomfort, upset, or paintrouble sleepingunable to sleepweight loss. For Healthcare Professionals. Applies to rotigotine: transdermal film extended release. Cardiovascular. Very common (1. Peripheral edema (up to 1. Common (1% to 1. 0%): Abnormal ECG T wave, first degree AV block, hypertension, palpitations. Uncommon (0. 1% to 1%): Atrial fibrillation. Rare (less than 0. Supraventricular tachycardia. These can be reported to the FDA here. Always consult a healthcare professional for medical advice. More about Neupro (rotigotine) Consumer resources Professional resources Related treatment guides. Disclaimer: Every effort has been made to ensure that the information provided is accurate, up- to- date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs. com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist. Rotigotine - Wikipedia, the free encyclopedia. Rotigotine. Systematic (IUPAC) name(S)- 6- . In 1. 99. 8, Aderis licensed worldwide development and commercialization rights for rotigotine to the Germanpharmaceutical company. Schwarz Pharma (today a subsidiary of the Belgian company UCB S. A.). In 2. 00. 7, the Neupro patch was approved by the Food and Drug Administration (FDA) as the first transdermal treatment of Parkinson's disease in the United States. However, as of 2. Schwarz Pharma has recalled all Neupro patches in the United States and some in Europe because of problems with the delivery mechanism. The patch was reformulated, and was reintroduced in the United States in 2. Rotigotine behaves as a partial or full agonist (depending on the assay) at all dopamine receptors listed, as an antagonist at the . Drugs of Today (Barcelona, Spain : 1. European Journal of Pharmacology. Synthesis and radioreceptor binding activity of N- 0. D2 dopamine receptor agonist. Pharm Weekbl Sci 1. PMID 2. 93. 36. 33^Development & Commercialization of rotigotine by Aderis (Aderis Pharmaceuticals making a reference for the commercialization of rotigotine)^Neupro Patch Re- launches in the US^Kulisevsky J, Pagonabarraga J (2. Archives of Neurology. Clinical Neuropharmacology. British Journal of Pharmacology. Naunyn- Schmiedeberg's Archives of Pharmacology.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
January 2017
Categories |